Browse evidence-based analysis of health-related claims and assertions
Log in to see full claim details, scientific mechanisms, and cited studies.
Getting the shingles vaccine reduces the chance of having a stroke by about 22%, and the newer version of the vaccine is more effective than the older one.
The virus that causes shingles can be found inside the walls of brain arteries in people who have had strokes, even when they never developed a rash, suggesting the virus directly damages blood...
When the chickenpox virus reactivates as shingles, it is linked to a higher chance of having a stroke, especially in the first two weeks after the rash appears, and this increased risk can last for...
Adults aged 50 and older who get both the shingles vaccine and start antiviral medication within a week of shingles have a 64% lower risk of dying within the next year than those who get neither.
Adults aged 50 and older who start antiviral medication within a week of shingles have a 29% lower risk of dying within the next year than those who don't take antivirals.
Adults aged 50 and older who get both the shingles vaccine and start antiviral medication within a week of shingles have a 39% lower risk of having a heart attack, stroke, or other cardiovascular...
Adults aged 50 and older who start antiviral medication within 7 days of developing shingles have a 22% lower risk of having a heart attack, stroke, or other cardiovascular problem in the next year...
Adults aged 50 and older who get the shingles vaccine after having shingles have a 21% lower risk of having a heart attack, stroke, or other cardiovascular event in the following year compared to...
In people with autoimmune diseases who received the herpes zoster vaccine, no cases of shingles were confirmed by laboratory testing during the 12-week study period, even though these patients are at...
In people with autoimmune diseases, the recombinant herpes zoster vaccine does not trigger more disease flares than a placebo shot, with similar rates of flare-ups observed in both groups after 12...
In people with autoimmune diseases, taking rituximab or mycophenolate mofetil severely reduces the immune system's ability to respond to the herpes zoster vaccine, with rituximab cutting the response...
In people with autoimmune rheumatic diseases, the recombinant herpes zoster vaccine triggers an immune response, but the level of protective antibodies produced is about 45% lower than in healthy...
In people with autoimmune rheumatic diseases, two doses of the recombinant herpes zoster vaccine given six weeks apart reduce the chance of common side effects like headache, fatigue, and fever by...
Adults aged 50 and older who receive the recombinant shingles vaccine have a 42.5% lower risk of being hospitalized for stroke and a 28% lower risk of being hospitalized for a heart attack, possibly...
In real-world use, the recombinant shingles vaccine prevents about 73% of cases of herpes zoster ophthalmicus — a serious eye infection — in adults aged 50 and older.
Adults aged 50 and older who receive two doses of the recombinant zoster vaccine have a 42.5% lower rate of being hospitalized for a stroke compared to those who are not vaccinated.
Adults aged 50 and older who receive two doses of the recombinant zoster vaccine have a 28% lower rate of being hospitalized for a heart attack compared to those who are not vaccinated.
Adults aged 50 and older who receive two doses of the recombinant zoster vaccine have a 73% lower rate of herpes zoster ophthalmicus, a serious eye infection caused by the shingles virus, compared to...
People with autoimmune diseases taking powerful immune-suppressing drugs like biologics or JAK inhibitors can safely receive the shingles vaccine without needing to pause their medication, as no...
In people with autoimmune diseases on immune-suppressing drugs, no one developed shingles after receiving the recombinant shingles vaccine during the six months after vaccination.
About 1 in 8 people with autoimmune diseases who start the two-dose shingles vaccine series do not complete it, mostly because they worry about having side effects after the first shot.
In people with autoimmune diseases like lupus or rheumatoid arthritis who are on immune-suppressing drugs, about 1 in 20 experienced a temporary worsening of their condition within two weeks after...
Among people with autoimmune diseases who are taking immune-suppressing medications, the shingles vaccine commonly causes mild soreness or redness at the injection site and sometimes temporary fever...
The number and types of health problems reported after the shingles vaccine in Chinese adults over 50 were similar to what has been seen in previous studies, and none of the patterns suggested a new...